Conference Description
Key Takeaways
- International conference addressing clinical trial innovation, regulatory harmonisation, and digital transformation
- Focus areas include decentralised trials, AI-powered analytics, real-world evidence integration, and patient-centric methodologies
- Designed for clinical operations leaders, regulatory professionals, CROs, research sites, and technology developers
- Explores adaptive trial designs, electronic data capture systems, and risk-based monitoring approaches
- Addresses emerging challenges in cybersecurity, blockchain applications, and pharmacovigilance
Introduction
The Global Clinical Trials Connect Conference brings together clinical researchers, regulatory specialists, and technology innovators to examine the evolving landscape of clinical research. As the pharmaceutical and biotechnology sectors face mounting pressure to accelerate drug development timelines while maintaining rigorous safety standards, this event addresses the operational, technological, and regulatory challenges shaping modern trial design and execution.
The conference programme spans topics from artificial intelligence applications in trial analytics to decentralised trial models that have gained significant traction following shifts in research methodology over recent years. With regulatory agencies worldwide increasingly accepting digital endpoints and remote monitoring data, the timing reflects an industry at a critical inflection point.
About This Event
The Global Clinical Trials Connect Conference serves as a platform for dialogue between sponsors, contract research organisations, investigator sites, technology vendors, and regulatory bodies. The event facilitates discussion on operational efficiency, compliance frameworks, and the integration of emerging technologies into established clinical workflows.
Sessions address both strategic considerations for senior leadership and practical implementation challenges faced by operational teams. The programme recognises that successful clinical research requires alignment across multiple stakeholder groups, from ethics committees and institutional review boards to supply chain specialists and data management professionals.
Digital Transformation and Decentralised Trial Models
A significant portion of the conference examines how digital health technologies are reshaping trial conduct. Decentralised and hybrid clinical trials, which reduce participant burden by enabling remote data collection and virtual visits, represent a fundamental shift from traditional site-centric models. These approaches rely on interconnected technologies including wearable devices, remote patient monitoring systems, and electronic consent platforms.
The programme explores electronic data capture systems, electronic clinical outcome assessments, and electronic patient-reported outcomes—technologies that have become essential infrastructure for modern trials. Understanding how these systems integrate with one another, and with legacy clinical data management platforms, remains a persistent challenge for research organisations.
Artificial Intelligence and Data Analytics in Clinical Research
Machine learning and artificial intelligence applications in clinical trials have moved beyond theoretical discussion into practical deployment. The conference addresses how these technologies support patient recruitment optimisation, protocol design, signal detection, and predictive analytics for trial outcomes. Big data approaches enable researchers to identify suitable patient populations more efficiently and to detect safety signals earlier in the development process.
Real-world evidence and real-world data integration represent another area of significant focus. Regulatory agencies have established frameworks for incorporating evidence generated outside traditional clinical trial settings, creating opportunities to supplement randomised controlled trial data with insights from electronic health records, claims databases, and patient registries.
Regulatory Compliance and Risk Management
Global regulatory harmonisation remains an ongoing challenge for sponsors conducting multinational trials. The conference examines how organisations navigate differing requirements across regulatory jurisdictions while maintaining consistent quality standards. Risk-based monitoring approaches, which allocate oversight resources according to identified risks rather than applying uniform monitoring intensity, have become standard practice but require sophisticated implementation.
Cybersecurity and data integrity concerns have grown alongside increased digitalisation. Blockchain applications in clinical research, while still maturing, offer potential solutions for ensuring data provenance and preventing unauthorised modifications to trial records.
Patient Centricity and Trial Accessibility
The conference emphasises patient-centric approaches that prioritise participant experience and trial accessibility. Diversity, equity, and inclusion strategies in clinical research have received heightened attention as the industry recognises that trial populations must reflect the patients who will ultimately use approved therapies. Effective patient recruitment and retention strategies directly impact trial timelines and data quality.
Who Should Attend
The conference is designed for professionals across the clinical research ecosystem, including clinical operations and trial management leaders, regulatory affairs specialists, and clinical data management experts. Representatives from contract research organisations, clinical trial sites, and sponsor companies will find relevant content, as will professionals working in pharmacovigilance, medical affairs, and post-market safety monitoring. Technology developers focused on digital health, wearables, and clinical trial software are also part of the intended audience, alongside investors evaluating opportunities in clinical research innovation.